• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察 C57BL/6-gfp 和 C57BL/6 小鼠之间相互交换的脂肪移植物的存活和血管生成情况。

Observations on the survival and neovascularization of fat grafts interchanged between C57BL/6-gfp and C57BL/6 mice.

机构信息

Xi'an, Shaanxi, People's Republic of China From the Institute of Plastic Surgery, Xijing Hospital, and the Departments of Oral and Maxillofacial Surgery and Implantation, School of Stomatology, Fourth Military Medical University.

出版信息

Plast Reconstr Surg. 2012 Sep;130(3):398e-406e. doi: 10.1097/PRS.0b013e31825dbfd3.

DOI:10.1097/PRS.0b013e31825dbfd3
PMID:22575853
Abstract

BACKGROUND

Autologous fat transplantation has become a prevalent option for soft-tissue augmentation throughout the body. However, there is still much controversy over whether the fat grafts have survived or have been replaced in the recipient sites and over how the vessels grow.

METHODS

After C57BL/6-gfp mice and C57BL/6 mice were paired randomly, the inguinal fat was excised and cut into pieces with scissors, and the adipose granules, approximately 0.2 ml (0.195 g), were transplanted subcutaneously with syringes to the dorsa of the paired mice. Samples were obtained at different time intervals: 3 days, 7 days, 2 weeks, 4 weeks, 2 months, 3 months, and 4 months after transplantation. Each fat sample was weighed to evaluate the graft volume. Histology, origin, and densities of neovascularization were examined by immunohistochemical staining.

RESULTS

At 4 months, there was no significant difference in either graft survival or histologic evaluation. Histologic evaluation manifested the normal physiologic process of inflammation, neovascularization, remodeling, and maturity at different time intervals. At the endpoint, the immunohistochemical staining of CD34 showed that the difference in capillary density of the fat graft-31.3 ± 3.9 capillaries/mm on the dorsa of the C57BL/6-gfp mice and 29.6 ± 3.2 capillaries/mm on the dorsa of the C57BL/6 mice-was not statistically significant. The α-smooth muscle actin staining indicated that there were neovascularized vessels in both C57BL/6-gfp and C57BL/6 fat grafts.

CONCLUSIONS

Fat grafts can survive and neovascularized vessels can grow from the recipient sites. Fat transplantation is feasible and will be applied more widely if fat graft survival is improved.

摘要

背景

自体脂肪移植已成为全身软组织填充的一种流行选择。然而,关于脂肪移植物是否在受区存活或被替代,以及血管如何生长,仍存在很多争议。

方法

将 C57BL/6-gfp 小鼠和 C57BL/6 小鼠随机配对,切除腹股沟脂肪,用剪刀剪成小块,用注射器将约 0.2ml(0.195g)脂肪颗粒移植到配对小鼠的背部皮下。在不同的时间间隔(移植后 3 天、7 天、2 周、4 周、2 个月、3 个月和 4 个月)获取样本。每个脂肪样本称重以评估移植物体积。通过免疫组织化学染色检查新生血管的起源和密度。

结果

在 4 个月时,移植物存活率或组织学评估均无显著差异。组织学评估显示在不同的时间间隔,有炎症、新生血管形成、重塑和成熟的正常生理过程。在终点时,CD34 的免疫组织化学染色显示,C57BL/6-gfp 小鼠背部脂肪移植物的毛细血管密度(31.3±3.9 个毛细血管/mm)与 C57BL/6 小鼠背部的毛细血管密度(29.6±3.2 个毛细血管/mm)之间的差异无统计学意义。α-平滑肌肌动蛋白染色表明,C57BL/6-gfp 和 C57BL/6 脂肪移植物中均有新生血管化的血管。

结论

脂肪移植物可以存活,受区可以生长新生血管。如果脂肪移植物的存活率提高,脂肪移植将更可行,并得到更广泛的应用。

相似文献

1
Observations on the survival and neovascularization of fat grafts interchanged between C57BL/6-gfp and C57BL/6 mice.观察 C57BL/6-gfp 和 C57BL/6 小鼠之间相互交换的脂肪移植物的存活和血管生成情况。
Plast Reconstr Surg. 2012 Sep;130(3):398e-406e. doi: 10.1097/PRS.0b013e31825dbfd3.
2
Observations on the survival and neovascularization of fat grafts interchanged between C57BL/6-gfp and C57BL/6 mice.关于在C57BL/6-gfp小鼠和C57BL/6小鼠之间交换的脂肪移植体的存活和新血管形成的观察
Plast Reconstr Surg. 2013 Apr;131(4):644e-645e. doi: 10.1097/PRS.0b013e3182827a97.
3
Targeted protection of donor graft vasculature using a phosphodiesterase inhibitor increases survival and predictability of autologous fat grafts.使用磷酸二酯酶抑制剂对供体移植血管进行靶向保护可提高自体脂肪移植的存活率和可预测性。
Plast Reconstr Surg. 2015 Feb;135(2):488-499. doi: 10.1097/PRS.0000000000000909.
4
Composite Microparticles of Fat Graft and GFR Matrigel Improved Volume Retention by Promoting Cell Migration and Vessel Regeneration.脂肪移植与GFR基质胶复合微粒通过促进细胞迁移和血管再生改善体积保留。
Aesthetic Plast Surg. 2024 May;48(10):1993-2001. doi: 10.1007/s00266-022-03145-6. Epub 2024 Feb 1.
5
The Fate of Fat Grafts in Different Recipient Areas: Subcutaneous Plane, Fat Pad, and Muscle.不同受体区域脂肪移植的转归:皮下平面、脂肪垫和肌肉。
Dermatol Surg. 2016 Apr;42(4):535-42. doi: 10.1097/DSS.0000000000000615.
6
Heat-Shock Protein 70 Overexpression in Adipose-Derived Stem Cells Enhances Fat Graft Survival.脂肪来源干细胞中热休克蛋白70的过表达可提高脂肪移植存活率。
Ann Plast Surg. 2017 Apr;78(4):460-466. doi: 10.1097/SAP.0000000000000968.
7
The Fate of the Adipose-Derived Stromal Cells during Angiogenesis and Adipogenesis after Cell-Assisted Lipotransfer.细胞辅助脂肪转移后血管生成和脂肪生成期间脂肪来源的基质细胞的命运。
Plast Reconstr Surg. 2018 Feb;141(2):365-375. doi: 10.1097/PRS.0000000000004021.
8
Treating fat grafts with human endothelial progenitor cells promotes their vascularization and improves their survival in diabetes mellitus.用人类内皮祖细胞处理脂肪移植物可促进其血管化,并提高其在糖尿病中的存活率。
Plast Reconstr Surg. 2012 Oct;130(4):801-811. doi: 10.1097/PRS.0b013e318262f12e.
9
[Experimental study of the effect of adipose stromal vascular fraction cells with VEGF on the neovascularization of free fat transplantation].[脂肪基质血管成分细胞联合血管内皮生长因子对游离脂肪移植新生血管形成影响的实验研究]
Zhonghua Zheng Xing Wai Ke Za Zhi. 2012 Mar;28(2):122-6.
10
Fate of adipose-derived stromal vascular fraction cells after co-implantation with fat grafts: evidence of cell survival and differentiation in ischemic adipose tissue.脂肪来源的基质血管成分细胞与脂肪移植物共植入后的命运:在缺血脂肪组织中细胞存活和分化的证据。
Plast Reconstr Surg. 2013 Aug;132(2):363-373. doi: 10.1097/PRS.0b013e31829588b3.

引用本文的文献

1
Improving Fat Graft Survival Using Soluble Molecule Preconditioning.利用可溶性分子预处理提高脂肪移植存活率
Biomolecules. 2025 Apr 3;15(4):526. doi: 10.3390/biom15040526.
2
Effectiveness and Safety of Different Methods of Assisted Fat Grafting: A Network Meta-Analysis.不同辅助脂肪移植方法的有效性和安全性的网状 Meta 分析。
Aesthetic Plast Surg. 2024 Jul;48(13):2484-2499. doi: 10.1007/s00266-024-04060-8. Epub 2024 May 21.
3
Establishment of Early Blood Perfusion Promotes CXCL12 Expression and Recruits Monocytes/Macrophages in Damaged Adipose Tissue in Mice Model.
早期血液灌注促进 CXCL12 表达并募集受损脂肪组织中的单核细胞/巨噬细胞,在小鼠模型中。
Aesthetic Plast Surg. 2024 Sep;48(17):3510-3519. doi: 10.1007/s00266-024-04103-0. Epub 2024 May 20.
4
Three-Dimensional Volumetric Analysis of the Effect of Interval Time in Autologous Fat Graft Breast Augmentation.自体脂肪移植隆乳术中间隔时间影响的三维容积分析
Aesthetic Plast Surg. 2023 Oct;47(5):1731-1739. doi: 10.1007/s00266-023-03367-2. Epub 2023 Apr 27.
5
Human antigen R promotes angiogenesis of endothelial cells cultured with adipose stem cells derived exosomes via overexpression of vascular endothelial growth factor in vitro.人抗原 R 通过体外过表达血管内皮生长因子促进与脂肪干细胞衍生的外泌体共培养的内皮细胞血管生成。
Adipocyte. 2021 Dec;10(1):475-482. doi: 10.1080/21623945.2021.1982577.
6
Review of Quantitative Imaging for Objective Assessment of Fat Grafting Outcomes in Breast Surgery.定量成像在乳房手术中脂肪移植效果的客观评估中的应用综述。
Aesthet Surg J. 2021 May 18;41(Suppl 1):S39-S49. doi: 10.1093/asj/sjab050.
7
Deciphering the Emerging Roles of Adipocytes and Adipose-Derived Stem Cells in Fat Transplantation.解析脂肪移植中脂肪细胞和脂肪来源干细胞的新兴作用。
Cell Transplant. 2021 Jan-Dec;30:963689721997799. doi: 10.1177/0963689721997799.
8
The miR-590-3p/VEGFA axis modulates secretion of VEGFA from adipose-derived stem cells, which acts as a paracrine regulator of human dermal microvascular endothelial cell angiogenesis.miR-590-3p/VEGFA 轴调节脂肪来源干细胞中 VEGFA 的分泌,其作为人真皮微血管内皮细胞血管生成的旁分泌调节剂起作用。
Hum Cell. 2020 Jul;33(3):479-489. doi: 10.1007/s13577-019-00315-8. Epub 2020 Apr 10.
9
Fat extract improves fat graft survival via proangiogenic, anti-apoptotic and pro-proliferative activities.脂肪提取物通过促进血管生成、抗细胞凋亡和促进增殖活性来提高脂肪移植的成活率。
Stem Cell Res Ther. 2019 Jun 13;10(1):174. doi: 10.1186/s13287-019-1290-1.
10
Augmentation of Dermal Wound Healing by Adipose Tissue-Derived Stromal Cells (ASC).脂肪组织来源的基质细胞(ASC)促进真皮伤口愈合
Bioengineering (Basel). 2018 Oct 26;5(4):91. doi: 10.3390/bioengineering5040091.